Gregor Leibundgut
Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.
Rubini Gimenez M, Scheller B, Farah A, Ohlow M, Mangner N, Weilenmann D, Wöhrle J, Cuculi F, Leibundgut G, Möbius-Winkler S, Cattaneo M, Gilgen N, Kaiser C, Jeger R. Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial. Clin Res Cardiol 2023
Jul 26, 2023Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.
Jul 26, 2023Clin Res Cardiol 2023
Rubini Gimenez Maria, Scheller Bruno, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Weilenmann Daniel, Wöhrle Jochen, Cuculi Florim, Leibundgut Gregor, Möbius-Winkler Sven, Cattaneo Marco, Gilgen Nicole, Kaiser Christoph A, Jeger Raban V
Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial.
Otto S, Díaz V, Weilenmann D, Cuculi F, Nuruddin A, Leibundgut G, Alfonso F, Wan Ahmad W, Pyxaras S, Rittger H, Steen P, Gaede L, Schulze C, Wöhrle J, Rosenberg M, Waliszewski M. Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial. BMC Cardiovasc Disord 2023; 23:176.
Mar 31, 2023Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial.
Mar 31, 2023BMC Cardiovasc Disord 2023; 23:176
Otto Sylvia, Díaz Victor Alfonso Jiménez, Weilenmann Daniel, Cuculi Florim, Nuruddin Amin Ariff, Leibundgut Gregor, Alfonso Fernando, Wan Ahmad Wan Azman, Pyxaras Stylianos, Rittger Harald, Steen Philip, Gaede Luise, Schulze Christian, Wöhrle Jochen, Rosenberg Mark, Waliszewski Matthias W
Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Seeger J, Wöhrle J, Scheller B, Farah A, Ohlow M, Mangner N, Möbius-Winkler S, Weilenmann D, Stachel G, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Jeger R, On Behalf Of The Basket-Small Investigators. Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial. J Cardiovasc Dev Dis 2023; 10
Mar 13, 2023Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Mar 13, 2023J Cardiovasc Dev Dis 2023; 10
Seeger Julia, Wöhrle Jochen, Scheller Bruno, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Möbius-Winkler Sven, Weilenmann Daniel, Stachel Georg, Leibundgut Gregor, Rickenbacher Peter, Cattaneo Marco, Gilgen Nicole, Kaiser Christoph A, Jeger Raban V, On Behalf Of The Basket-Small Investigators
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial.
Scheller B, Rissanen T, Farah A, Ohlow M, Mangner N, Wöhrle J, Möbius-Winkler S, Weilenmann D, Leibundgut G, Cuculi F, Gilgen N, Coslovsky M, Mahfoud F, Jeger R, BASKET-SMALL 2 Investigators. Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial. Circ Cardiovasc Interv 2022; 15:e011569.
Apr 12, 2022Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial.
Apr 12, 2022Circ Cardiovasc Interv 2022; 15:e011569
Scheller Bruno, Rissanen Tuomas T, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Wöhrle Jochen, Möbius-Winkler Sven, Weilenmann Daniel, Leibundgut Gregor, Cuculi Florim, Gilgen Nicole, Coslovsky Michael, Mahfoud Felix, Jeger Raban V, BASKET-SMALL 2 Investigators
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial.
Mahfoud F, Farah A, Ohlow M, Mangner N, Wöhrle J, Möbius-Winkler S, Weilenmann D, Leibundgut G, Cuculi F, Gilgen N, Kaiser C, Cattaneo M, Scheller B, Jeger R. Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial. Clin Res Cardiol 2022; 111:806-815.
Feb 27, 2022Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial.
Feb 27, 2022Clin Res Cardiol 2022; 111:806-815
Mahfoud Felix, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Wöhrle Jochen, Möbius-Winkler Sven, Weilenmann Daniel, Leibundgut Gregor, Cuculi Florim, Gilgen Nicole, Kaiser Christoph, Cattaneo Marco, Scheller Bruno, Jeger Raban V
Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
Mangner N, Farah A, Ohlow M, Möbius-Winkler S, Weilenmann D, Wöhrle J, Linke A, Stachel G, Markovic S, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Scheller B, Jeger R, BASKET-SMALL 2 Investigators. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2. Circ Cardiovasc Interv 2022; 15:e011325.
Jan 10, 2022Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
Jan 10, 2022Circ Cardiovasc Interv 2022; 15:e011325
Mangner Norman, Farah Ahmed, Ohlow Marc-Alexander, Möbius-Winkler Sven, Weilenmann Daniel, Wöhrle Jochen, Linke Axel, Stachel Georg, Markovic Sinisa, Leibundgut Gregor, Rickenbacher Peter, Cattaneo Marco, Gilgen Nicole, Kaiser Christoph, Scheller Bruno, Jeger Raban V, BASKET-SMALL 2 Investigators
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial
Wöhrle J, Jeger R, Kaiser C, Gilgen N, Cattaneo M, Rickenbacher P, Leibundgut G, Stachel G, Weilenmann D, Möbius-Winkler S, Mangner N, Ohlow M, Farah A, Seeger J, Scheller B, BASKET-SMALL 2 Investigators. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial. JACC Cardiovasc Interv 2021; 14:1789-1798.
Jan 23, 2021Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial
Jan 23, 2021JACC Cardiovasc Interv 2021; 14:1789-1798
Wöhrle Jochen, Jeger Raban V, Kaiser Christoph, Gilgen Nicole, Cattaneo Marco, Rickenbacher Peter, Leibundgut Gregor, Stachel Georg, Weilenmann Daniel, Möbius-Winkler Sven, Mangner Norman, Ohlow Marc-Alexander, Farah Ahmed, Seeger Julia, Scheller Bruno, BASKET-SMALL 2 Investigators
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial
Jeger R, Scheller B, Kaiser C, Gilgen N, Cattaneo M, Osswald S, Rickenbacher P, Leibundgut G, Markovic S, Stachel G, Wöhrle J, Weilenmann D, Möbius-Winkler S, Mangner N, Ohlow M, Farah A, BASKET-SMALL 2 Investigators. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet 2020; 396:1504-1510.
Oct 19, 2020Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial
Oct 19, 2020Lancet 2020; 396:1504-1510
Jeger Raban V, Scheller Bruno, Kaiser Christoph, Gilgen Nicole, Cattaneo Marco, Osswald Stefan, Rickenbacher Peter, Leibundgut Gregor, Markovic Sinisa, Stachel Georg, Wöhrle Jochen, Weilenmann Daniel, Möbius-Winkler Sven, Mangner Norman, Ohlow Marc-Alexander, Farah Ahmed, BASKET-SMALL 2 Investigators
Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial
Stöhr R, Sanders-van Wijk S, Pfisterer M, Jeker U, Schuh A, Leibundgut G, Maeder M, Heine G, Brandenburg V, Brunner-La Rocca H. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. Eur J Heart Fail 2020
Feb 5, 2020Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial
Feb 5, 2020Eur J Heart Fail 2020
Stöhr Robert, Sanders-van Wijk Sandra, Pfisterer Matthias, Jeker Urs, Schuh Alexander, Leibundgut Gregor, Maeder Micha, Heine Gunnar H, Brandenburg Vincent M, Brunner-La Rocca Hans-Peter
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial
Jeger R, Stephan F, Mueller C, Rickenbacher P, Coslovsky M, Gilgen N, Osswald S, Kaiser C, Scheller B, Linke A, Mahfoud F, Schreiber M, Farah A, Ohlow M, Mangner N, Möbius-Winkler S, Leibundgut G, Weilenmann D, Wöhrle J, Richter S, BASKET-SMALL 2 Investigators. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 2018; 392:849-856.
Aug 28, 2018Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial
Aug 28, 2018Lancet 2018; 392:849-856
Jeger Raban V, Stephan Frank-Peter, Mueller Christian, Rickenbacher Peter, Coslovsky Michael, Gilgen Nicole, Osswald Stefan, Kaiser Christoph, Scheller Bruno, Linke Axel, Mahfoud Felix, Schreiber Matthias, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Möbius-Winkler Sven, Leibundgut Gregor, Weilenmann Daniel, Wöhrle Jochen, Richter Stefan, BASKET-SMALL 2 Investigators
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2
Gilgen N, Butter C, Bruch L, Kaiser C, Hoffmann A, Rickenbacher P, Mueller C, Stephan F, Coslovsky M, Jeger R, Krackhardt F, Zweiker R, Farah A, Scheller B, Ohlow M, Mangner N, Weilenmann D, Wöhrle J, Jamshidi P, Leibundgut G, Möbius-Winkler S, BASKET-SMALL 2 Investigators. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2. Clin Cardiol 2018; 41:569-575.
May 10, 2018Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2
May 10, 2018Clin Cardiol 2018; 41:569-575
Gilgen Nicole, Butter Christian, Bruch Leonhard, Kaiser Christoph, Hoffmann Andreas, Rickenbacher Peter, Mueller Christian, Stephan Frank-Peter, Coslovsky Michael, Jeger Raban, Krackhardt Florian, Zweiker Robert, Farah Ahmed, Scheller Bruno, Ohlow Marc-Alexander, Mangner Norman, Weilenmann Daniel, Wöhrle Jochen, Jamshidi Peiman, Leibundgut Gregor, Möbius-Winkler Sven, BASKET-SMALL 2 Investigators
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF
Davarzani N, Peeters R, Rickenbacher P, Pfisterer M, Gutmann M, Leibundgut G, Maeder M, Karel J, Sanders-van Wijk S, Brunner-La Rocca H. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF. J Card Fail 2017; 23:382-389.
Feb 13, 2017N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF
Feb 13, 2017J Card Fail 2017; 23:382-389
Davarzani Nasser, Peeters Ralf, Rickenbacher Peter, Pfisterer Matthias E, Gutmann Marc, Leibundgut Gregor, Maeder Micha, Karel Joël, Sanders-van Wijk Sandra, Brunner-La Rocca Hans-Peter
Predictors of early readmission or death in elderly patients with heart failure
Muzzarelli S, Brunner-La Rocca H, Pfisterer M, Buser P, Jeker U, Gutmann M, Handschin R, Rickli H, Maeder M, Leibundgut G, TIME-CHF Investigators. Predictors of early readmission or death in elderly patients with heart failure. Am Heart J 2010; 160:308-14.
Aug 1, 2010Predictors of early readmission or death in elderly patients with heart failure
Aug 1, 2010Am Heart J 2010; 160:308-14
Muzzarelli Stefano, Brunner-La Rocca Hans-Peter, Pfisterer Matthias, Buser Peter, Jeker Urs, Gutmann Marc, Handschin Rolf, Rickli Hans, Maeder Micha, Leibundgut Gregor, TIME-CHF Investigators